Scios Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIOS LLC, and what generic and branded alternatives to SCIOS LLC drugs are available?
SCIOS LLC has one approved drug.
Summary for Scios Llc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Scios Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Scios Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | 5,114,923 | ⤷ Subscribe |
| Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | 6,974,861 | ⤷ Subscribe |
| Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | 5,674,710 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
